Adaptimmune Therapeutics (ADAPY) Q2 2025 Earnings Report

1,252 Followers

ADAPY Q2 2025 EPS Results

Actual EPS-$0.02

Consensus EPS-$0.04

Beat/MissBeat by +$0.02

One Year Ago EPS$0.04

Actual Revenue$13.85M

Expected Revenue$8.60M

Beat/MissBeat by +$5.25M

YoY Revenue Growth-89.21%

QuarterQ2 2025

Date08/13/2025

TimeBefore Open

Conference CallWednesday, August 13, 2025

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 12, 2026	2026 (Q2)	- / -	-0.116	―
May 20, 2026	2026 (Q1)	-0.03 / -	-0.03	―
Mar 10, 2026	2025 (Q4)	-0.06 / -0.03	-0.05	40.00% (+0.02)
Nov 05, 2025	2025 (Q3)	-0.12 / -	-0.01	―
Aug 13, 2025	2025 (Q2)	-0.04 / -0.02	0.04	-150.00% (-0.06)
May 13, 2025	2025 (Q1)	-0.09 / -0.03	-0.03	0.00% (0.00)
Mar 20, 2025	2024 (Q4)	-0.03 / -0.05	-0.04	-25.00% (-0.01)
Nov 13, 2024	2024 (Q3)	>-0.01 / -0.01	-0.03	66.67% (+0.02)
Aug 12, 2024	2024 (Q2)	-0.04 / 0.04	-0.02	300.00% (+0.06)
May 15, 2024	2024 (Q1)	-0.15 / -0.03	0	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed